324 related articles for article (PubMed ID: 18715329)
1. Pathways to the best fit of triptans for migraine patients.
Buzzi MG
Cephalalgia; 2008 Sep; 28 Suppl 2():21-7. PubMed ID: 18715329
[TBL] [Abstract][Full Text] [Related]
2. [Triptans--pivotal event in migraine treatment].
Lusić I; Bilić I
Acta Med Croatica; 2008 May; 62(2):173-8. PubMed ID: 18710081
[TBL] [Abstract][Full Text] [Related]
3. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
[TBL] [Abstract][Full Text] [Related]
4. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
Sandrini G; Dahlöf CG; Mathew N; Nappi G
Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
[TBL] [Abstract][Full Text] [Related]
5. Oral almotriptan: practical uses in the acute treatment of migraine.
Dowson AJ
Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
[TBL] [Abstract][Full Text] [Related]
6. Almotriptan: meeting today's needs in acute migraine treatment.
Láinez MJ
Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
[TBL] [Abstract][Full Text] [Related]
7. Which triptan for which patient?
Rapoport AM; Tepper SJ; Sheftell FD; Kung E; Bigal ME
Neurol Sci; 2006 May; 27 Suppl 2():S123-9. PubMed ID: 16688615
[TBL] [Abstract][Full Text] [Related]
8. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
9. Predictors of adherence to triptans: factors of sustained vs lapsed users.
Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
[TBL] [Abstract][Full Text] [Related]
10. Almotriptan in triptan-naïve patients: new evidence of benefits.
Pascual J
Cephalalgia; 2008 Sep; 28 Suppl 2():14-20. PubMed ID: 18715328
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic evaluation of almotriptan for the treatment of migraines.
Negro A; Lionetto L; D'Alonzo L; Casolla B; Marsibilio F; Vignaroli G; Simmaco M; Martelletti P
Expert Opin Drug Metab Toxicol; 2013 May; 9(5):637-44. PubMed ID: 23570251
[TBL] [Abstract][Full Text] [Related]
12. A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.
Gori S; Morelli N; Acuto G; Caiola F; Iudice A; Murri L
Minerva Med; 2006 Dec; 97(6):467-77. PubMed ID: 17213783
[TBL] [Abstract][Full Text] [Related]
13. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
[TBL] [Abstract][Full Text] [Related]
14. Use of almotriptan in triptan-experienced and triptan-naïve patients.
Pascual J; Diener HC
Curr Med Res Opin; 2007 Oct; 23(10):2433-40. PubMed ID: 17723158
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
17. Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy.
Gentile G; Borro M; Simmaco M; Missori S; Lala N; Martelletti P
Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):39-47. PubMed ID: 21142809
[TBL] [Abstract][Full Text] [Related]
18. Rizatriptan in migraine.
Krymchantowski AV; Bigal ME
Expert Rev Neurother; 2005 Sep; 5(5):597-603. PubMed ID: 16162083
[TBL] [Abstract][Full Text] [Related]
19. Applying the benefits of the AwM study in the clinic.
Dodick DW
Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
